Causes of Peripheral Blood Cytopenias in Patients with Liver Cirrhosis Portal Hypertension and Clinical Significances


Liver cirrhosis portal hypertension patients to reduce the number of blood cells are common in clinical, and often affect the prognosis. This paper discusses cirrhotic portal hypertension patients complicated by the reason of the decrease in the number of peripheral blood cells and what is the clinical significance of these reasons so as to provide theoretical support for the choice of treatment. Splenomegaly and hypersplenism caused should be the main reason for reducing the number of blood cells, but not all, other reasons are alcohol and virus inhibition of bone marrow, liver function impairment, autoimmune damage and loss of blood, etc. If it is a function of the spleen hyperfunction caused by blood cells decreases, blood should rise to normal after splenectomy, or consider other reason or there are other reasons at the same time.

Share and Cite:

Lv, Y. (2014) Causes of Peripheral Blood Cytopenias in Patients with Liver Cirrhosis Portal Hypertension and Clinical Significances. Open Journal of Endocrine and Metabolic Diseases, 4, 85-89. doi: 10.4236/ojemd.2014.44010.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Lv, Y.-F., Li, X.-Q. Huang, W.-W., et al. (2007) Peripheral Blood Cytopenia in Patients with Hypersplenism Due to Portal Hypertension. Chinese Journal of General Surgery, 22, 702.
[2] Bashour, F.N., Teran, J.C. and Mullen, K.D. (2000) Prevalence of Peripheral Blood Cytopenias (Hypersplenism) in Patients with Nonalcoholic Chronic Liver Disease[J]. Gastroenterology, 95, 2936-2939.
[3] Van, E., Niele, A.M. and Kroes, A.C. (1999) Human Parvovirus B19: Relevance in Internal Medicine[J]. The New England Journal of Medicine, 54, 221-230.
[4] Kevin, E., Brown, J.T., Barrett, A.J., et al. (1997) Hepatitis-Associated Aplastic Anemia[J]. The New England Journal of Medicine, 1059-1064.
[5] Dilloo, D., Vohringer, R., Josting, A., et al. (1995) Bone Marrow Fibroblasts from Children with Aplastic Anemia Exhibit Reduced Interlukin-6 Production in Response to Cytokines and Viral Challenge[J]. Pediatric Research, 38, 716-721.
[6] Young, N.S. and Maciejewski, J. (1997) The Pathophysiology of Acquired Aplastic Anemia[J]. The New England Journal of Medicine, 336, 1365-1372.
[7] Jacobs, J.S. and Miller, M.W. (2001) Proliferation and Death of Cultured Fetal Neocortical Neurons: Effects of Ethanol on the Dynamics of Cell Growth[J]. Journal of Neurocytology, 30, 391-401.
[8] Hao, L.P., Hu, X.F., Pang, H., et al. (2006, The Study on Apoptosis and Its Molecular Mechanism in Mouse Insulinama Cells Induced by Ethanol[J]. Journal of Toxicology, 20, 138-140.
[9] Neuman, M.G., Haber, J.A., Malkiewicz, I.M., et al. (2002) Ethanol Signals for Apoptosis in Cultured Skin Cells[J]. Alcohol, 26, 179-190.
[10] Djordjevic, J., Svorcan, P., Vrinic, D. and Dapcevic, B. (2010) Splenomegaly and Thrombocytopenia in Patients with Liver Cirrhosis. Vojnosanit Pregl, 67, 166-169.
[11] Sezai, S., Kamisaka, K., Ikegami, F., et al. (1998) Regulation of Hepatic Thrombopoietin Production by Portal Hemodynamics in Liver Cirrhosis[J]. The American Journal of Gastroenterology, 93, 80-82.
[12] Lu, Y.F., Yue, J., Gong, X.G., et al. (2009) Anaemia of Cirrhotic Portal Hypertension with Hypersplenism. Journal of Surgery: Concepts & Practice, 14, 669-670.
[13] Wolber, E.M., Ganschow, R., Burdelski, M., et al. (1999) Hepatic Thrombopoietin mRNA Levels in Acute and Chronic Liver Failure of Childhood[J]. Hepatology, 29, 1739-1742.
[14] Forbes, S.J., Russo, F.P., Rey, V., et al. (2004) A Significant Proportion of Myofibroblasts Are of Bone Marrow Origin in Human Liver Fibrosis[J]. Gastroenterology, 126, 955-963.
[15] Shah, S.H., Hayes, P.C., Allan, P.L., et al. (1996) Measurement of Spleen Size and Its Relation to Hypersplenism and Portal Hemodynamics in Portal Hypertension Due to Hepatic Cirrhosis[J]. The American Journal of Gastroenterology, 91, 2580-2583.
[16] Jiao, Y.F., Okumiya, T., Saibara, T., Kudo, Y. and Sugiura, T. (2001) Erythrocyte Creatine as a Marker of Excessive Erythrocyte Destruction Due to Hypersplenism in Patients with Liver Cirrhosis. Clinical Biochemistry, 34, 395-398.
[17] Friedman, L.S. (1999) The Risk of Surgery in Patients with Liver Disease. Hepatology, 29, 1617-1623.
[18] Zhou, Y.X. (2002) Modern Diagnostics & Therapeutics of Liver Cirrhosis. 1st Edition, People’s Military Medical Press, Beijing, 247-249.
[19] Faeh, M., Hauser, S.P. and Nydegger, U.E. (2001) Transient Thrombopoietin Peak after Liver Transplantation for End-Stage Liver Disease. British Journal of Haematology, 112, 493-498.
[20] Lv, Y.F., Li, X.Q., Han, X.Y., Gong, X.G. and Chang, S.W. (2013) Peripheral Blood Cell Variations in Cirrhotic Portal Hypertension Patients with Hypersplenism. Asian Pacific Journal of Tropical Medicine, 6, 663-666.
[21] Lv, Y.F. (2009) Characteristics and Clilical Significance of Hypersplenism Secondary to Splenomegaly Caused by Cirrhotic Portal Hypertension. World Chinese Journal of Digestology, 17, 2969-2971.
[22] Lv, Y.F., Li, X.Q., Gong, X.G., Xie, X.H., Han, X.Y. and Wang, B.C. (2013) Effect of Surgery Treatment on Hypersplenism Caused by Cirrhotic Portal Hypertension. Minerva Chirurgica, 68, 409-413.

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.